Mr. Thomas Papalaskaris | Municipality of Kavala | Greece

-


 

Comments

Post a Comment

Popular posts from this blog

Japan’s Innovative Approach to Artificial Intelligence Legislation

-
Image
  Japan introduced law aimed at encouraging artificial intelligence (AI) research and development. This legislation, known as the Act on the Promotion of Research, Development and Utilisation of Artificial Intelligence-Related Technologies, seeks to position Japan as a leader in the global AI landscape. The law diverges from stringent regulatory frameworks like the European Union’s AI Act, instead promoting an innovation-driven environment. Key Features of Japan’s AI Law The Act establishes an Artificial Intelligence Strategy Headquarters under the Cabinet. This body is responsible for formulating a national Basic Plan for AI. The plan encompasses foundational research, industrial deployment, international collaboration, and public education. The law avoids rigid regulatory frameworks and focuses on enabling innovation and encouraging cooperation among stakeholders. Comparison with the European Union’s AI Act In contrast to Japan’s approach, the EU’s AI Act employs a risk-based cl...
Read more

EMM-Negative Blood Group System

-
Image
  The International Society of Blood Transfusion officially recognised a new blood group system named EMM-negative, also known as Gwada negative. This designation emerged from the unique case of a woman from Guadeloupe who is the only known individual to possess this rare blood type. The discovery puts stress on advancements in transfusion medicine and genetic research. What is Gwada Negative? Gwada negative refers to the EMM-negative blood group system, identified by the absence of the EMM antigen on red blood cells. This antigen is a high-incidence antigen, present in almost all humans. The lack of such a common antigen is medically and has led to the classification of this blood type as the 48th globally recognised system in transfusion science. Discovery Process The identification of the EMM-negative blood type began in 2011 when the woman underwent routine blood tests. Initial attempts to classify her blood were inconclusive due to the lack of technology. In 2019, advancement...
Read more

EU’s General-Purpose AI Code of Practice

-
Image
  The General-Purpose AI (GPAI) Code of Practice was published on 10 July 2025. It aims to help AI industry players comply with the European Union’s AI Act. This voluntary framework addresses safety, transparency, and copyright obligations for providers of general-purpose AI models. Member States and the European Commission are currently reviewing the Code’s adequacy. Following endorsement, AI providers who adopt the Code can demonstrate legal compliance more easily and reduce administrative burdens. Purpose and Scope of the GPAI Code of Practice The Code assists providers of general-purpose AI models to meet legal duties under the AI Act. It is designed through a multi-stakeholder process involving independent experts. The Code is voluntary but offers legal certainty and easier compliance proof. It focuses on three main areas – transparency, copyright, and safety and security. The latter applies specifically to providers of highly advanced AI models with systemic risks. Transpare...
Read more